RESPONSIBILITIES

• Perform studies to improve the identity, purity, and potency of engineered cell product
• Perform scale-up and close-system processes to ensure reproducibility of drug product
• Establish tracking and trending analyses of process development, pilot and cGMP production runs
• Good understanding of cGMP environment
• Draft documentation (protocols, batch records, reports) to standardize and transfer CERO’s manufacturing processes to a CMO
• Determine development activities, technology transfer activities, timelines and resource needs to meet corporate goals
• Rigorously document study results at a level to support IND filings
• Present results in team meetings and deliver presentations to both small and large groups

QUALIFICATIONS AND EXPERIENCE

• Demonstrated capability to conduct and optimize human cell engineering methods
• Strong candidates will have familiarity with flow cytometry
• Experience in T cell isolation, culture, and freezing is preferred
• Experience in cell-based therapy culture and process development experience
• MS/PhD in biology, molecular and cell biology, immunology or related field
• 3 or more years industry experience within biotech/pharmaceutical company or a CRO/CMO
• Demonstrated ability to prioritize efforts, achieve objectives, meet deadlines, adapt, and excel in a close, fast-paced team environment
• Ability to communicate effectively with strong oral and verbal communications skills
• CMC regulatory knowledge and cGMP experience in the cell therapy space is preferred

Please contact [email protected] or [email protected] if interested

About CERo Therapeutics

CERo Therapeutics, Inc. is a privately held biopharmaceutical company pioneering cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company’s CER-T platform lies at the intersection of innate and adaptive cell clearance, combining the body’s natural signaling mechanisms, which are capable of recognizing and disposing of unwanted cells, with traditional T cell killing. This integrated approach draws on recent advances in molecular immunology and insights related to the downstream signaling of specialized receptors that cooperate to ingest and eliminate dangerous cells and pathogens. To learn more about the company and its pioneering science, please visit www.cero.bio.